Physician profile
Racquel E Hedman Gatica
NPI 1699492181
$1,419.79
in general payments reported to CMS, 2019-2025
10 companies · $279 in 2025
The $279 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $92.00 · 2023: $440 · 2024: $609 · 2025: $279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,328.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,327.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $491.03 | 2022-2025 | |
| Alcon Vision LLC | $341.70 | 2022-2024 | Rocklatan |
| Sun Pharmaceutical Industries INC. | $328.60 | 2022-2024 | Cequa |
| Bausch & Lomb Americas INC. | $97.53 | 2024-2025 | Miebo, Vyzulta |
| Mallinckrodt Hospital Products INC. | $37.97 | 2024 | Acthar |
| Harrow Eye, LLC | $32.15 | 2024 | Natacyn, Verkazia, Tobradex St |
| Glaukos Corporation | $24.59 | 2024 | Istent Trabecular Micro-Bypass System Model Is3 |
| Dompe US, INC. | $24.26 | 2024 | Oxervate |
| Tarsus Pharmaceuticals, INC. | $21.31 | 2025 | Xdemvy |
| Astellas Pharma US INC | $20.65 | 2025 | Izervay |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Racquel Hedman Gatica listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.